Currently available therapies such as niacin and PCSK9 inhibitors such as Repatha (evolocumab) and Praluent (alirocumab) can reduce Lp (a) levels, but their impact is modest. Another challenge in ...

A new study found that having higher lipoprotein(a) levels was linked to an increased 30-year risk for cardiovascular disease ...

Elevated levels of lipoprotein (a) is a genetic disease that causes cardiovascular disease. Steven Nissen, M.D., addresses why it’s important to find treatments for this genetic risk factor.

Very high Lp(a) also correlated with higher risks of ischemic stroke and cardiovascular mortality in the Women’s Health Study ...

KUTV — Heart disease remains the leading cause of death in America, and while many are aware of the impact of lifestyle choices on heart health, few realize the critical role that genetics can play.

Colino is a contributor for TIME. Colino is a contributor for TIME. TC, HDL, LDL: There’s an alphabet soup of cholesterol types to know about. Relatively new on the scene is Lp(a), or lipoprotein(a).